RxDoctor Payments Data

Eric Carter, MD

Otolaryngology · New Albany, INNPI 1740285113

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.2% of the total across 121 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 23.6% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $807, 3.2 times the $254 reported in 2019.

$2,922in general payments, 2019–2025

Across 121 payments — averaging $24.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron Healthcare Solutions, Inc.$689
  • Optinose US, Inc.$425
  • Inspire Medical Systems, Inc.$291
  • Stryker$262
  • Sanofi$207
  • GSK$138
  • plus $911 from 17 others
$48,687in research payments, 2019–2025

Across 4 payments — averaging $12,172 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Aerin Medical Inc.$49K

What the payments were for

  • Food & beverage$2,86998%
  • Education$542%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,922 in reported general payments places this provider in the 70th percentile of 193 otolaryngology providers in Indiana.

See all otolaryngology providers in Indiana

Medicare billing

Part B allowed, 2024
$165,444
Medicare patients
717
Services billed
4,742

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Azelastine Hcl178$4,321
Ofloxacin34$2,306
Pilocarpine Hcl15$1,138
Ipratropium Bromide64$1,136
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth15$1,075
Fluticasone Propionate74$744
Pantoprazole Sodium91$649
Montelukast Sodium67$605
Albuterol Sulfate HfaAlbuterol Sulfate14$335
Methylprednisolone46$280
Famotidine20$207
Mupirocin49$194
Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid12$162
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim13$57

Paid to pharmacies, not to this prescriber.

Other otolaryngology in New Albany

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →